NUOBIKAN (02635) · Company profile · Eqvero

NUOBIKAN

02635HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022
Revenue	498.16 m CNY	402.64 m CNY	363.7 m CNY	252.62 m CNY
Cost of revenue	199.68 m CNY	155.75 m CNY	149.48 m CNY	110.83 m CNY
Research and development expense	82.95 m CNY	59.56 m CNY	56.65 m CNY	44.49 m CNY
Selling, general and administrative expense	56.56 m CNY	52.15 m CNY	36.18 m CNY	25.92 m CNY
Operating profit after depreciation	116.7 m CNY	108.73 m CNY	90.4 m CNY	54.63 m CNY
Operating profit before depreciation	148.99 m CNY	118.38 m CNY	93.27 m CNY	56.06 m CNY
EBIT	116.7 m CNY	108.73 m CNY	90.4 m CNY	54.63 m CNY
EBITDA	148.99 m CNY	118.38 m CNY	93.27 m CNY	56.06 m CNY
Interest expense	4.17 m CNY	3.42 m CNY	2.32 m CNY	1.44 m CNY
Profit before tax	130.62 m CNY	126.1 m CNY	96.86 m CNY	72.56 m CNY
Income tax expense	12.77 m CNY	10.74 m CNY	8.29 m CNY	9.39 m CNY
Income before extraordinary items	117.84 m CNY	115.37 m CNY	88.57 m CNY	63.16 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.